The Patent Finder

Terms ending in 2029

Mesoblast, Inc.

Every in-force patent on Mesoblast, Inc.'s record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 8,858,932Repair And/Or Reconstitution of Invertebral Discs
In force
 · High confidence
Mesoblast, Inc.In forceHigh confidence
US 12,558,382Repair And/Or Reconstruction of Invertebral Discs
In force
 · High confidence
Mesoblast, Inc.In forceHigh confidence
US 9,815,896Monoclonal Antibody STRO-4
In force
 · High confidence
Mesoblast, Inc.In forceHigh confidence
US 8,828,375Expansion of Haemopoietic Precursors
In force
 · High confidence
Mesoblast, Inc.In forceHigh confidence
US 9,480,713Method for Treating Diabetic Renal Failure or Syndrome X
In force
 · High confidence
Mesoblast, Inc.In forceHigh confidence
US 9,968,640Method for Treating or Preventing a Pancreatic Dysfunction
In force
 · Medium confidence
Mesoblast, Inc.In forceMedium confidence
US 9,090,678Monoclonal Antibody STRO-4
In force
 · High confidence
Mesoblast, Inc.In forceHigh confidence
7 of 7 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited